Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71,941,794
-
Number of holders
-
438
-
Total 13F shares, excl. options
-
67,516,262
-
Shares change
-
+577,383
-
Total reported value, excl. options
-
$10,147,693,254
-
Value change
-
+$89,380,655
-
Put/Call ratio
-
20%
-
Number of buys
-
214
-
Number of sells
-
-180
-
Price
-
$150.33
Significant Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q4 2019
495 filings reported holding WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock as of Q4 2019.
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 438 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 67,516,262 shares
of 71,941,794 outstanding shares and own 94% of the company stock.
Largest 10 shareholders include BlackRock Inc. (8,158,920 shares), VANGUARD GROUP INC (7,499,113 shares), PRICE T ROWE ASSOCIATES INC /MD/ (6,830,989 shares), FRANKLIN RESOURCES INC (4,445,600 shares), STATE STREET CORP (2,734,074 shares), Neuberger Berman Group LLC (2,275,706 shares), BAMCO INC /NY/ (1,487,587 shares), Capital Research Global Investors (1,438,129 shares), JPMORGAN CHASE & CO (1,350,837 shares), and WCM INVESTMENT MANAGEMENT, LLC (1,338,119 shares).
This table shows the top 438 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.